Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Options trading offers unique opportunities to boost investment returns. Discover how to leverage options for greater gains.
25,570 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A new AI-driven supercycle is unfolding, but you don’t need to chase dramatic bets. This guide explains how agentic A...
Gold prices hovering near $4,000 can prompt questions about safety, liquidity, and potential gains. This guide helps ...
If you crave steady income, a better high-yield dividend etf can be a powerful tool. This in-depth comparison of VYM ...
Choosing to claim Social Security at 62 is a turning point in retirement planning. This guide explains how that decis...
A looming major social security deadline could reshape retirement planning. This article explains what it is, why it ...
Alphabet reports results after the bell, but the line that matters most might be capex. This guide shows how data-cen...
Geopolitical risk in the Middle East is reshaping energy markets. Five high-yield energy stocks offer robust dividend...
A powerful stock rebound in META reshaped fortunes and sparked a closer look at risk, diversification, and wealth dyn...
Upstart has stunned the market with a renewed focus on AI-powered lending, but questions remain. This article breaks ...
A tariff reversal can trigger a short-lived stock market surge, but gains often fade as details unfold. This guide ex...
A trusted news figure faced early memory changes that changed more than his schedule. This article uses that story to...